Year Founded
1983
Ownership
Private
Employees
~100
Therapeutic Areas
NeurologyPsychiatry
Stage
Commercial
Modalities
Small molecule

Breckenridge Pharmaceutical General Information

Generic pharmaceutical company focused on developing and marketing high-quality, cost-effective generic drugs in the United States

Contact Information

Website
Primary Industry
Pharma
Corporate Office

Drug Pipeline

everolimus
Commercial
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum
Drug Asset 2
Phase X
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum
Drug Asset 3
Phase X
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum

For full access to Breckenridge Pharmaceutical's pipeline data

Book a demo

Key Partnerships

Towa International, ESTEVE, Cypress Pharmaceutical, Nostrum Laboratories

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

Breckenridge Pharmaceutical Funding

No funding data available

Early Stage VC (Series A)04-Jun-2020$38MCompletedPhase 1
Seed Round12-Feb-2019$8.5MCompletedStartup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more
To view Breckenridge Pharmaceutical's complete valuation and funding history, request access »

Breckenridge Pharmaceutical Investors

$1 million in funding mentioned, specific investors not listed
Investor Type: Venture Capital
Holding: Minority